- Lobbying
- Lindsay AND Bealor
Lobbying Arrangements Results for 'Lindsay Bealor'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Legislation and regulation affecting health risk assessments. |
Matrix Medical Network
|
THE MCMANUS GROUP | |||
Details Regulatory and legislative activities regarding 340B program. Access and reimbursement issues in Medicare Part D. |
ELI LILLY AND COMPANY
|
THE MCMANUS GROUP | |||
Details Advanced molecular diagnostic policy. Laboratory and pathology coverage and payment issues. |
Caris Life Sciences, Inc.
|
THE MCMANUS GROUP | |||
Details Education and advocacy regarding pediatric and rare disease programs at the FDA. |
XOMA Corporation
|
THE MCMANUS GROUP | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Johnson & Johnson
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Medicare reimbursement for radiation oncology treatment. MACRA Implementation (PL No: 114-10) |
Radiation Therapy Alliance
|
THE MCMANUS GROUP | |||
Details MACRA Implementation (81 FR 28161). Opposition to Part B Demo (81 FR 13229) Issues relating to Opioid abuse. Increased funding for treatment of Opioid addiction. HR 953 & S. 524: Comprehensive Addi... |
AMERICAN MEDICAL ASSOCIATION
|
THE MCMANUS GROUP | |||
Details Medicare Parts B and D drugs payments and access. |
ALLERGAN, INC.
|
THE MCMANUS GROUP | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
The Medicines Company
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Tetraphase Pharmaceuticals
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Microbion Corporation
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
AstraZeneca
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
GlaxoSmithKline
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Spero Opco, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Astellas Pharma US, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Zavante Therapeutics, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Merck & Co., Inc.
Client manufacturers and develops pharmaceuticals, vaccines and biologic therapies. |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Allergan, Plc.
Allergan is a diversified global pharmaceutical company |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details General health care coverage and reimbursement; issues related to infectious disease drug development and procurement; legislative and regulatory issues related to biodefense countermeasure develop... |
Achaogen
|
THE MCMANUS GROUP | |||
Details Issues related health savings accounts (HSAs) and individual coverage health reimbursement arrangements (ICHRAs) including in H.R.3799 - CHOICE Arrangement Act. H.R. 5688, the Bipartisan HSA Impro... |
WEX Health
|
THE MCMANUS GROUP | |||
Details Increased patient access and reimbursement to procedures in ambulatory surgical centers including in H.R. 972/S. 312 - Outpatient Surgery Quality and Access Act of 2023. Site neutrality provisions... |
Ambulatory Surgery Center Association
|
THE MCMANUS GROUP | |||
Details Continued access to occupational therapy services including in the Stabilizing Medicare Access to Rehabilitation and Therapy (SMART) Act. Continued expansion of telehealth services in H.R. 3875, S... |
American Occupational Therapy Association
|
THE MCMANUS GROUP | |||
Details Access and reimbursement of medical devices in Medicare program including in H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023. Issues related to Transitional Covera... |
MEDICAL DEVICE MANUFACTURERS ASSOCIATION
|
THE MCMANUS GROUP | |||
Details General pharmaceutical coverage and reimbursement issues, issues and activities affecting oncology, neurodegenerative and fertility products. Issues related to reforming and increasing transparenc... |
EMD Serono, Inc.
|
THE MCMANUS GROUP | |||
Details Access and reimbursement of Part B Drugs in Medicare. Continued expansion of Telehealth services including in the H.R. 3857 - Expanded Telehealth Access Act and Telehealth Modernization Act. H.R.... |
Digestive Health Physicians Association, Inc.
|
THE MCMANUS GROUP | |||
Details H.R.5391, S. 2764 - Protecting Patient Access to Cancer and Complex Therapies Act Access and reimbursement of Part B Drugs in Medicare. Continued expansion of Telehealth services including in the... |
Large Urology Group Practice Association
|
THE MCMANUS GROUP |